PNC Financial Services Group
CAPR icon

PNC Financial Services Group’s Capricor Therapeutics CAPR Stock Holding History

PNC Financial Services Group’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.12K Buy
118
+97
+462% +$1.07K ﹤0.01% 4978
2026
Q2 		$506 Sell
21
-3
-13% -$91 ﹤0.01% 4984
2026
Q1 		$730 Buy
24
+3
+14% +$80 ﹤0.01% 4825
2025
Q4 		$606 Sell
21
-217
-91% -$2.83K ﹤0.01% 4799
2025
Q3 		$1.72K Buy
+238
New +$1.75K ﹤0.01% 4544

Other funds holding CAPR

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JHC
Jones Hill Capital New York $589M AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
DG Capital Management
DG Capital Management New York $451M AUM 20.71% 1-Year Est. Return

PNC Financial Services Group's CAPR Position: Q3 2026 in Review

PNC Financial Services Group increased its Capricor Therapeutics (CAPR) stake by 462% in Q3 2026, buying an estimated $1.07K and bringing the position to 118 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #4978.

PNC Financial Services Group first reported a position in CAPR in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.72K in Q3 2025. 95 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.

  • PNC Financial Services Group held 118 shares of Capricor Therapeutics worth $1.12K as of Q3 2026.
  • PNC Financial Services Group bought 97 Capricor Therapeutics shares in Q3 2026, an estimated $1.07K.
  • Capricor Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4978 holding.
  • PNC Financial Services Group first reported a position in Capricor Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • PNC Financial Services Group's Capricor Therapeutics position peaked at $1.72K in Q3 2025.
  • 95 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.